Effects of amylin on bone minernal density and structure parameters of bone tissue in glucocorticoid-induced osteoporosis rats

陆邦超,王坚,乔飞

DOI: https://doi.org/10.3969/j.issn.1008-8199.2003.05.007

2003-01-01

Abstract:Objectives:To investigate the effects of amylin on bone minernal density and structure parameters of bone tissue in glucocorticoid induced osteoporosis rats. Methods:Four groups of female Wistar rats (3 months old) were treated for 12 weeks as follows: ⅠNormal Control, ⅡDXM, Ⅲ DXM+AMY;Ⅳ DXM+Vitamin Da 3. By intramuscular injection of dexamethasone(XM)1mg/kg twice a week during the first 8 weeks, the animal model of Glucocorticoid induced osteopoprosis was established. After 12 weeks, BMD of the lumbar vertebrae and the femural bone were measured by DEXA. The bone morphology of the lumbar vertebrae was also determined. Results:①After the treatment with AMY, bone mineral density (BMD) was significantly increased at the lumbar spine and the femural bone. ( vs. DXM group, P 0.01). The BMD of the lumbar vertebrae was also higher in DXM+VitD than that in DXM rats ( P 0.05), but it was not different at the femural bone between these two groups.②Histological analysis showed that the trabecular volume was significantly increased in DXM+AMY, compared to the DXM group. The increase in trabecular volume was contributed to by increases in trabecular thickness and trabecular number and from a decline in trabecular separation. The same changes were also observed in the DXM+VitD group. Conclusions:AMY can effectively inhibit the bone loss in GIO rats, which indicates a widespread prospect in use of amylin as a new anti osteoporosis drug.